» Articles » PMID: 38790616

Differences in Airway Remodeling and Emphysematous Lesions Between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties

Overview
Date 2024 May 25
PMID 38790616
Authors
Affiliations
Soon will be listed here.
Abstract

Genes from and were introduced into L. var. HHY via distant hybridization, and the new-type tobacco varieties "Zisu" and "Luole" were developed, with noticeable differences in chemical composition. Smoking is the leading cause of chronic obstructive pulmonary disease (COPD), and its pathogenesis is complex. In the present study, 48 male Sprague-Dawley (SD) rats were randomly divided into four groups, namely, the control, "HHY", "Zisu" and "Luole", and then exposed to fresh air/cigarette smoke (CS) for 30 days and 60 days. The COPD model was constructed, and their health hazards were compared and evaluated. CS from different tobacco varieties influenced rats in varying degrees at the tissue, cell and molecular levels. The rats in the "HHY" group showed obvious symptoms, such as cough and dyspnea, which were less severe in the "Zisu" and "Luole" groups. Pathological and morphological analyses, including scores, MLI, MAN, WAt/Pbm and WAm/Pbm, showed that "Zisu" and "Luole" caused less damage to the airways and lung parenchyma than "HHY". Significant increases in the numbers of total leukocytes and neutrophils in the BALF were found in "HHY" compared to those in "Zisu" and "Luole". Moreover, they caused less oxidative stress and apoptosis in lung tissues, as reflected by indicators such as ROS, MDA, T-AOC, GSH, the apoptotic index and the ratio of Bcl-2 to Bax. "Zisu" and "Luole" even altered the ratios of MMP-9/TIMP-1 and IFN-γ/IL-4 in lung tissues to a lesser degree. These differences between CS-exposed rats may be closely related to the altered expression of Nrf2, p38 MAPK and p-p38 MAPK. Changes in chemical composition via introducing genes from some medicinal plants may be an attractive strategy for tobacco harm reduction.

Citing Articles

Animal models of chronic obstructive pulmonary disease: a systematic review.

Feng T, Cao J, Ma X, Wang X, Guo X, Yan N Front Med (Lausanne). 2024; 11:1474870.

PMID: 39512624 PMC: 11540622. DOI: 10.3389/fmed.2024.1474870.

References
1.
Rustemeier K, Stabbert R, Haussmann H, Roemer E, Carmines E . Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol. 2001; 40(1):93-104. DOI: 10.1016/s0278-6915(01)00085-0. View

2.
Barnes P . Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxidants (Basel). 2022; 11(5). PMC: 9138026. DOI: 10.3390/antiox11050965. View

3.
Kirkham P, Rahman I . Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther. 2006; 111(2):476-94. DOI: 10.1016/j.pharmthera.2005.10.015. View

4.
Horvath G, Acs K . Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti-inflammatory action: a review. Flavour Fragr J. 2020; 30(5):331-341. PMC: 7163989. DOI: 10.1002/ffj.3252. View

5.
Chen M, Lv Z, Jiang S . The effects of triptolide on airway remodelling and transforming growth factor-β₁/Smad signalling pathway in ovalbumin-sensitized mice. Immunology. 2011; 132(3):376-84. PMC: 3044903. DOI: 10.1111/j.1365-2567.2010.03392.x. View